GeneDx Holdings Corp. (WGS) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $129.37M | +16.5% |
| 2024 | $111.05M | -1.3% |
| 2023 | $112.56M | -56.9% |
| 2022 | $261.44M | +14.3% |
| 2021 | $228.80M | +30.5% |
| 2020 | $175.30M | +54.6% |
| 2019 | $113.39M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $129.37M | +16.5% |
| 2024 | $111.05M | -1.3% |
| 2023 | $112.56M | -56.9% |
| 2022 | $261.44M | +14.3% |
| 2021 | $228.80M | +30.5% |
| 2020 | $175.30M | +54.6% |
| 2019 | $113.39M | — |